Oenanthe Crocata (Hahnemann Laboratories, Inc.)


Welcome to the PulseAid listing for the Oenanthe Crocata drug offered from Hahnemann Laboratories, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Hahnemann Laboratories, Inc.
NON-PROPRIETARY NAME: Oenanthe Crocata
SUBSTANCE NAME: OENANTHE CROCATA ROOT
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: BUCCAL; ORAL; SUBLINGUAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2016-12-01
END MARKETING DATE: 0000-00-00


Oenanthe Crocata HUMAN OTC DRUG Details:

Item DescriptionOenanthe Crocata from Hahnemann Laboratories, Inc.
LABELER NAME: Hahnemann Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 30([hp_C]/[hp_C])
START MARKETING DATE: 2016-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63545-664_44bd9411-0c78-1729-e054-00144ff88e88
PRODUCT NDC: 63545-664
APPLICATION NUMBER:

Other OENANTHE CROCATA ROOT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hahnemann Laboratories, Inc.Oenanthe Crocata
Rxhomeo Private Limited d.b.a. Rxhomeo, IncOENANTHE CROCATA